Forget about Jenrry Mejia helping out the Mets. Forget about Jenrry Mejia helping out any team.
It’s three strikes and you’re out.
The Mets’ former closer has been permanently suspended after testing positive for a performance enhancing drug three times in less than a year. Major League Baseball announced Friday evening that Mejia, who was serving a 162-game suspension, has now tested positive for the PED Boldenone.
Mejia is the first player, in the minors or majors, who has received a lifetime ban for a third positive PED test in violation of the MLB’s Joint Drug Policy. He can apply for reinstatement in the game, but must serve at least two years of a suspension.
The Mets released a statement expressing their disappointment with Mejia.
“We were deeply disappointed to hear that Jenrry has again violated Major League Baseball’s Joint Drug Prevention and Treatment Program. We fully support MLB’s policy toward eliminating performance enhancing substances from the sport. As per the Joint Drug Program, we will have no further comment on this suspension,” the team said in a statement.
Mejia originally was suspended for 80 games in April for the steroids Stanozolol and Boldenone. Less than a month after his July return from that suspension, Mejia was handed a full-season suspension for testing positive for Stanozolol.
This is a developing story, check back for updates
This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.